Company news

Bio-Techne Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bio-Techne commercializes RNAscope spatial biology workflow for the Standard BioTools Hyperion Imaging System

May 15, 2023

Bio-Techne to present at the 2023 rbc capital markets global healthcare conference

May 11, 2023

BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA

May 9, 2023

Bio-Techne releases third quarter fiscal 2023 results

May 2, 2023

Bio-Techne to present at the bofa securities 2023 health care conference

May 1, 2023

Bio-Techne and Lunaphore establish strategic partnership to develop the first fully automated same-slide spatial multiomics solution

April 16, 2023

Bio-Techne to showcase innovative cancer research, cell therapy and manufacturing tools at aacr 2023 conference

April 12, 2023

Bio-Techne to host conference call on May 3, 2023, to announce third quarter 2023 financial results

April 11, 2023

Bio-Techne celebrates milestone with more than 1,000 Ella™ instruments now in operation

April 4, 2023

Bio-Techne completes investment in Wilson Wolf Manufacturing

April 2, 2023

Bio-Techne announces completion of Cell and Gene Therapy Catapult process analytical technology (PAT) consortium

March 14, 2023

Bio-Techne to present at the barclays global healthcare conference

March 9, 2023

Bio-Techne announces investment in Wilson Wolf

February 28, 2023

Bio-Techne to present at the cowen 43rd annual health care conference

February 27, 2023

ExoDx PROSTATE TEST GRANTED EXPANDED COVERAGE BY MEDICARE

February 23, 2023

Bio-Techne to present at the citi 2023 healthcare services, medtech, tools & hcit conference

February 21, 2023

Bio-Techne and Cell Signaling Technology announce partnership to validate Simple Western antibodies

February 13, 2023

Bio-Techne releases second quarter fiscal 2023 results

February 1, 2023

Bio-Techne announces retirement, appointment of General Counsel

January 30, 2023

BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS

January 25, 2023

Bio-Techne to host conference call on February 2, 2023, to announce second quarter 2023 financial results

January 16, 2023

Bio-Techne launches RNAscope Plus assay to advance gene therapy development

January 9, 2023

Bio-Techne to present at the 41st annual j.p. morgan healthcare conference

December 20, 2022

Bio-Techne releases MitoBrilliant™ fluorescent dyes, providing a next-generation tool for imaging mitochondria in live and fixed cells

December 4, 2022

Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market

November 30, 2022

BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE

November 27, 2022

Namocell highlighted in nature publication for efficient single cell cloning of human pluripotent stem cells

November 16, 2022

Bio-Techne announces opening of new immunoassay manufacturing facility

November 14, 2022

Bio-Techne to present at the stephens annual investment conference

November 9, 2022

Bio-Techne to present at the stifel 2022 healthcare conference

November 7, 2022

Bio-Techne to present at the credit suisse 31st annual healthcare conference

November 2, 2022

Bio-Techne releases first quarter fiscal 2023 results

October 31, 2022

Bio-Techne declares cash dividend and stock dividend

October 31, 2022

New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

October 17, 2022

Bio-Techne sets a new standard in highly sensitive RNA imaging with the introduction of vivid fluorescent dyes for spatial biology

October 11, 2022

Bio-Techne introduces new Simple Plex AAV viral titer assays

October 10, 2022

Bio-Techne to host conference call on November 1, 2022, to announce first quarter 2023 financial results

October 9, 2022

Bio-Techne commercializes automated multi-omic RNAscope assays for spatial visualization of RNA and protein biomarkers in ffpe tissues

October 5, 2022

Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments

September 25, 2022

Bio-Techne issues 2022 corporate sustainability report

September 18, 2022

Bio-Techne presents initial data on Sjögren's Syndrome monitoring assay

September 7, 2022

Bio-Techne to seek approval to implement four-for-one stock split

August 31, 2022

Bio-Techne announces release of Quantist Luminex® data analysis software

August 17, 2022

Bio-Techne announces CEO transition plan

August 3, 2022

Bio-Techne announces licensing agreement and partnership with University of Dundee

July 27, 2022

Bio-Techne to host conference call on August 4, 2022, to announce fourth quarter 2022 financial results

July 13, 2022

Bio-Techne launches new Turbo CE-SDS™ cartridge, accelerating protein purity analysis throughput by 400%

July 11, 2022

Bio-Techne Announces Launch of the CE-IVD RNAscope™ ISH Probe High Risk HPV Assay for Head and Neck Cancer

July 5, 2022

Bio-Techne announces completion of Namocell acquisition

July 4, 2022

Bio-Techne to acquire Namocell

June 21, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.